SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
600.00    -10.00 (-1.64%)
Bid:
598.00
Ask:
600.00
Spread: 2.00 (0.334%)
Market Cap: £726.05m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Oxford Biomedica News

Oxford Biomedica swings to EBITDA profit
15 Apr 2021

Oxford Biomedica swings to EBITDA profit

(Sharecast News) - Oxford Biomedica reported a 37% improvement in total revenues in its preliminary results on Thursday, to £87.7m.

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal
15 Apr 2021

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

UK earnings, trading statements calendar - next 7 days
8 Apr 2021

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim
6 Apr 2021

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Oxford Biomedica strikes three-year deal with Boehringer Ingelheim
6 Apr 2021

Oxford Biomedica strikes three-year deal with Boehringer Ingelheim

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelhe...

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders
6 Apr 2021

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

EU rebuffs UK calls to ship AstraZeneca COVID vaccines from Europe
21 Mar 2021

EU rebuffs UK calls to ship AstraZeneca COVID vaccines from Europe

By Francesco GuarascioBRUSSELS, March 21 (Reuters) - The European Union is rebuffing British government calls to ship AstraZeneca COVID-19 vaccines ...

Sanofi to terminate haemophilia development pact with Oxford Biomedica
19 Mar 2021

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Sanofi to terminate haemophilia development pact with Oxford Biomedica